TxCell announces its financial calendar for 2015

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today its financial calendar for 2015. 

February 4, 2015: Publication of full year 2014 revenues (after market)

April 1, 2015: Publication of 2014 annual results (after market)

May 6, 2015: Publication of Q1 2015 revenues (after market)

May 26, 2015: Annual shareholders’ meeting

August 4, 2015: Publication of Q2 2015 revenues (after market)

September 22, 2015: Publication of H1 2015 results (after market)

November 5, 2015: Publication of Q3 2015 revenues (after market)

In addition to these updates, investors can consult the website of the company (www.txcell.com) where information is regularly updated. All corporate and financial information on the company is available on the company’s website, in the Finance section.